Clinical Trials Directory

Trials / Unknown

UnknownNCT00347828

Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose

Prospective Study Comparing the Effectiveness of Zymar and Vigamox for Preoperative Antibiotic Sterilization of the Ocular Surface After Loading Dose

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (planned)
Sponsor
Ophthalmic Consultants of Boston · Academic / Other
Sex
All
Age
25 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to analyze the effect of Zymar and Vigamox on ocular surface bacteria. We believe that Zymar will eradicate more ocular surface bacteria than Vigamox.

Detailed description

Topical antibiotics are frequently used before surgical procedures with the intent of targetting and reducing the number of bacteria on the surface of the eye. These bacteria serve as potential sources for post-operative infection. One commonly used method is the administration of antibiotic drops 3 times: 1 hour prior to surgery at intervals of 5 minutes. Studies in the lab have shown that the preservative benzalkonium chloride 0.005%, part of the Zymar antibiotic drop preparation, allows the antibiotic to act more effectively than the antibiotic Vigamox, which does not include this preservative. Comparison: The effect of Zymar antibiotic eye drops on conjunctival cultures compared to the effect of Vigamox on conjunctival cultures as measured by conjunctival cultures taken prior to treatment and then one hour after administration of eye drops 3 times, at 5 minute intervals.

Conditions

Interventions

TypeNameDescription
DRUGMoxifloxacin ophthalmic solution 0.5%
DRUGGatifloxacin ophthalmic solution 0.3%

Timeline

Start date
2006-06-01
Completion
2006-06-01
First posted
2006-07-04
Last updated
2006-07-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00347828. Inclusion in this directory is not an endorsement.